Remote Guided Caffeine Reduction

Summary

Remote Guided Caffeine Reduction is a clinical trial^[1].

Key Facts

• Remote Guided Caffeine Reduction is in the country of United States^[2].
• Remote Guided Caffeine Reduction's instance of is recorded as clinical trial^[3].
• Remote Guided Caffeine Reduction's start time is recorded as +2020-09-30T00:00:00Z^[4].
• Remote Guided Caffeine Reduction's end time is recorded as +2022-08-31T00:00:00Z^[5].
• Remote Guided Caffeine Reduction's contributor to the creative work or subject is recorded as National Institute on Drug Abuse^[6].
• Remote Guided Caffeine Reduction's sponsor is recorded as Johns Hopkins University^[7].
• Remote Guided Caffeine Reduction's main subject is recorded as diarrhea^[8].
• Remote Guided Caffeine Reduction's main subject is recorded as heartburn^[9].
• Remote Guided Caffeine Reduction's number of participants is recorded as {'unit': '1', 'amount': '+36'}^[10].
• Remote Guided Caffeine Reduction's title is recorded as Remote Guided Caffeine Reduction^[11].
• Remote Guided Caffeine Reduction's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[12].
• Remote Guided Caffeine Reduction's ClinicalTrials.gov ID is recorded as NCT04560595^[13].
• Remote Guided Caffeine Reduction's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[14].
• Remote Guided Caffeine Reduction's research intervention is recorded as caffeine^[15].
• Remote Guided Caffeine Reduction's research subject recruitment status is recorded as recruiting^[16].
• Remote Guided Caffeine Reduction's study type is recorded as interventional study^[17].